Due to Generic Erosion, the Hypertension Drug Market Will Decline by $3 Billion from 2009 to 2019
Advertisement
Novartis's Diovan/Tareg Will Suffer the Greatest Decline As Its Sales Will Decrease More Than $1 Billion in 2013, According to Findings from Decision Resources